retatrutide formula Formula, C221H342N46O - RetatrutideChemical Name Protein Chemical Formula: Not Available Unraveling the Retatrutide Formula: A Deep Dive into a Promising Therapeutic Peptide

Retatrutidefor sale The retatrutide formula is a subject of increasing interest, particularly within the medical and scientific communities. This novel peptide, identified by its CAS No. 2381089-83-2, is recognized for its potential in metabolic disease managementRetatrutide - BPS Bioscience. While the exact retatrutide formula can vary slightly across different sources and contexts, the most commonly cited and scientifically validated molecular formulas include C221H342N46O68 and C221H342N46O. Variations such as C187H281N43O60 and even C223H343F3N46O70 have also been noted, potentially representing different salt forms or modified versions of the peptide.

The Molecular Architecture of Retatrutide

At its core, retatrutide is a peptide, a chain of amino acids linked together. Its impressive molecular weight, often calculated to be around 4731 g/mol or 4731.33 Da, underscores its complexity. This substantial size is characteristic of therapeutic peptides designed for specific biological interactions. The retatrutide sequence, instrumental in its biological activity, is a testament to intricate polypeptide design. While the precise full sequence isn't always readily available in summary data, key components and structural insights are emerging from research.

Retatrutide is distinguished as a triple glucagon hormone receptor agonist. This means it simultaneously targets and activates three critical receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR).RETATRUTIDE This multi-target approach is a significant advancement in the pursuit of effective treatments for conditions like obesity and type 2 diabetes. The detailed retatrutide chemical structure and its precise amino acid arrangement are crucial for understanding its mechanism of action and pharmacokinetic properties.

Variations in Reported Formulas and Their Implications

The presence of different molecular formulas, such as C221H342N46O68 and C221H342N46O, can be attributed to how the peptide is represented.Retatrutide - CID 171390338 - PubChem - NIH The inclusion of oxygen atoms (O68 vsRetatrutide - Mikon Biotechnology Co., Ltd. O) might signify the presence of additional oxygen-containing functional groups or hydration states associated with the peptide. Furthermore, the formula C221H342N46O68•XNa indicates the sodium salt form of retatrutide, a common practice in pharmaceutical formulation to enhance solubility and stability.

The presence of formulas like C187H281N43O60 and C223H343F3N46O70 suggests potential modifications or precursor forms. The latter, containing fluorine atoms, might refer to a fluorinated analog being investigated, which can sometimes alter metabolic stability or binding affinity. It's essential for researchers and clinicians to be aware of these distinctions when referring to specific research or product data.

Availability and Research Context

Understanding the retatrutide formula is paramount for those involved in its research, development, and potential clinical applicationMolecularFormula: C221H342N46O68. Molecular Weight: 4731.3. Data sheet: View or download. Product Description:Retatrutide(LY3437943) is a triple agonist .... While direct purchase for personal use is prohibited, retatrutide for sale is available through specialized chemical suppliers for research purposes, often with purity levels of 99CN117777248A - Water-based solid phase synthesis ....4% peptide or ≥95%. Information regarding retatrutide cost is typically provided by these suppliers and can vary based on quantity and purity.

The exploration of retatrutide ingredients list would primarily focus on its amino acid composition, which dictates the overall formulaRetatrutide (LY3437943), 99.4% purity peptide ; Peptide Purity (HPLC). 99.42% ; Molecular Formula.C221H342N46O; Molecular Weight. 4731.33 ; CAS No. 2381089-83-2.. The retatrutide sequence is the blueprint for its synthesis. Currently, retatrutide is primarily accessible through participation in clinical trials, offering a pathway to obtain and utilize this peptide under medical supervision. Resources from organizations like the National Institutes of Health (NIH) through platforms like PubChem offer detailed chemical information, including molecular formulas and synonyms like LY3437943.

Beyond the Formula: Efficacy and Future Prospects

The significance of the retatrutide formula extends far beyond its atomic composition. It is the foundation upon which its therapeutic efficacy is built. As a triple agonist, retatrutide demonstrates remarkable potential for weight loss and improving glycemic control, positioning it as a potential game-changer in obesity pharmacotherapy. Ongoing research, including cryo-electron microscopy studies revealing insights into its interaction with target receptors, continues to deepen our understanding of this complex molecule.Molecular Formula, CHEMICAL, ESTIMATEDC187H281N43O60; MOL_WEIGHT:NUMBER(CALCULATED), CHEMICAL, ESTIMATED 4091.546 Da (average) ... The journey from understanding the retatrutide formula and retatrutide chemical name to its therapeutic realization is a testament to scientific innovation in peptide drug development.